| Name | 3-Bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine |
|---|---|
| Synonyms |
3-bromo-6-chloro-2-methylimidazo/1,2-b/pyridazine
3-Bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine 3-Brom-6-chlor-2-methyl-imidazo<1,2-b>pyridazin S14-2932 Imidazo[1,2-b]pyridazine, 3-bromo-6-chloro-2-methyl- |
| Density | 1.9±0.1 g/cm3 |
|---|---|
| Molecular Formula | C7H5BrClN3 |
| Molecular Weight | 246.492 |
| Exact Mass | 244.935532 |
| PSA | 30.19000 |
| LogP | 2.36 |
| Index of Refraction | 1.732 |
| HS Code | 2933990090 |
|---|
|
~%
18112-31-7 |
| Literature: NOVARTIS AG Patent: WO2008/52733 A1, 2008 ; Location in patent: Page/Page column 81 ; WO 2008/052733 A1 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |